2021 ICD-10-CM Code C50.1

Malignant neoplasm of central portion of breast

Version 2021

Not Valid for Submission

C50.1 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of central portion of breast. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic breast (connective tissue) (glandular tissue) (soft parts) central portion .

ICD-10:C50.1
Short Description:Malignant neoplasm of central portion of breast
Long Description:Malignant neoplasm of central portion of breast

Code Classification

Specific Coding for Malignant neoplasm of central portion of breast

Non-specific codes like C50.1 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for malignant neoplasm of central portion of breast:

  • NON-BILLABLE CODE - C50.11 for Malignant neoplasm of central portion of breast, female
  • BILLABLE CODE - Use C50.111 for Malignant neoplasm of central portion of right female breast
  • BILLABLE CODE - Use C50.112 for Malignant neoplasm of central portion of left female breast
  • BILLABLE CODE - Use C50.119 for Malignant neoplasm of central portion of unspecified female breast
  • NON-BILLABLE CODE - C50.12 for Malignant neoplasm of central portion of breast, male
  • BILLABLE CODE - Use C50.121 for Malignant neoplasm of central portion of right male breast
  • BILLABLE CODE - Use C50.122 for Malignant neoplasm of central portion of left male breast
  • BILLABLE CODE - Use C50.129 for Malignant neoplasm of central portion of unspecified male breast

Table of Neoplasms

The code C50.1 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »breast (connective tissue) (glandular tissue) (soft parts)
    »central portion
C50.1C79.81D05.D24.D48.6D49.3

Information for Patients


Breast Cancer

Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include

Other risks include obesity, using hormone replacement therapy (also called menopausal hormone therapy), taking birth control pills, drinking alcohol, not having children or having your first child after age 35, and having dense breasts.

Symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast, and discharge from a nipple. Breast self-exams and mammography can help find breast cancer early, when it is most treatable. One possible treatment is surgery. It could be a lumpectomy or a mastectomy. Other treatments include radiation therapy, chemotherapy, hormone therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

Men can have breast cancer, too, but it is rare.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)